1. Introduction {#sec1}
===============

Rice is perhaps the most widely cultivated food crop world over, but its production is constrained by diseases of fungal, bacterial, and viral origins. Bacterial leaf blight (BLB) of rice, caused by *Xanthomonas oryzae*pv. *oryzae* (*Xoo*) is a very destructive disease and its incidence has been reported from different parts of Asia, northern Australia, Africa, and USA \[[@B1]--[@B3]\]. The disease is known to occur in epidemic proportions in many parts of the world, incurring severe crop loss of up to 50% \[[@B1], [@B2], [@B4]\]. In West Africa, disease incidence ranged from 70 to 85% and yield loss ranged from 50 to 90%, indicating a wide spread of BLB disease in farmers\' fields \[[@B2], [@B4]\]. Some selected *Xoo* isolates have shown high level of pathogenicity and virulence on the cultivated rice varieties \[[@B4]\]. Research studies have also revealed that BLB is an important rice disease in irrigated rice ecosystems in West Africa, mainly in Sahelian and Sudano-Sahelian countries \[[@B2], [@B5]\]. Crop loss assessment studies have revealed that this disease reduces grain yield to varying levels, depending on the stage of the crop, degree of cultivar susceptibility, and, to a great extent, the conduciveness of the environment in which it occurs \[[@B6]\]. The severity and significance of damage caused by infection have necessitated the development of strategies to control and manage the disease, so as to reduce crop loss and to avert an epidemic. Though the use of Bordeaux mixture, antibiotics, and other copper and mercurial compounds were resorted to in the early fifties, environmentally safe and stable chemical control agents rendering control at very low concentrations are yet to be developed \[[@B7]\]. Today, the exploitation of host resistance appears to be the only reliable method of disease management. The identification and characterization of major genes for qualitative resistance and polygenic factors controlling quantitative resistance have contributed a great deal to the success in breeding resistant cultivars and their deployment \[[@B8]\]. Recent research has provided considerable evidence that the deployment of bacterial antagonists to *Xoo* might be an effective strategy, bringing about disease suppression by biological control \[[@B9]\].

To understand the epidemiology and ecology of *Xoo* pathogens and their potential for virulence change, various phenotypic characters as well as molecular markers have been used in studies of *Xoo* pathogen population structure \[[@B3], [@B4], [@B10], [@B11]\]. Rapid identification and classification of bacteria are normally carried out by morphology, nutritional requirements, antibiotic resistance, isozyme comparisons, phage sensitivity \[[@B7], [@B10], [@B12]\], and more recently DNA based methods, particularly rRNA sequences \[[@B13], [@B14]\], strain-specific fluorescent oligonucleotides \[[@B15]\], and the polymerase chain reaction (PCR) \[[@B12], [@B16]\]. Several repetitive elements found in the *Xoo* pathogen have been used as probes in restriction fragment length polymorphism (RFLP) analysis \[[@B17]\]. However, for the large number of samples needed for ecological and virulence studies, a simpler and cheaper technology is required. PCR is increasingly becoming an important tool in population biology, because of its simplicity and potential to rapidly screen a large number of samples with a minimal amount of DNA.

In West Africa several *Xoo* genetic studies have been conducted and different *Xoo* pathotypes identified but little information is available on *Xoo* virulence genotypes population structure and distribution \[[@B10], [@B11], [@B18]\]. The virulence pathotypes of several *Xoo*isolates from West African countries based on cultivars reactions have been determined \[[@B4], [@B5], [@B19]\]. The main goal of this study is to determine *Xoo* virulence genotypes using the characterized *Xoo* isolates virulence pathotypes identified by Onasanya et al. \[[@B4]\] using random amplified polymorphic DNA polymerase chain reaction (RAPD-PCR) assays. The identification and differentiation of different *Xoo* virulence genotypes and distribution in West Africa would greatly help rice breeding improvement programs aiming at the effective development of rice cultivars with durable resistance to BLB disease.

2. Materials and Methods {#sec2}
========================

2.1. Research Location {#sec2.1}
----------------------

Bacterial isolate propagation and molecular PCR analysis were carried out at Central Biotechnology Laboratory, International Institute of Tropical Agriculture (IITA), Ibadan, Nigeria. This study was conducted between February and May 2009.

2.2. Bacterial Isolates {#sec2.2}
-----------------------

Fifty *Xanthomonas oryzae*pv.*oryzae*(*Xoo*) isolates ([Table 1](#tab1){ref-type="table"}) used in this study were from Onasanya et al. \[[@B4]\]. The identity of all the fifty *Xoo* isolates had been confirmed by oxidative biochemical test as well as their virulence pathotypes \[[@B4]\].

2.3. Isolates Propagation {#sec2.3}
-------------------------

BLB isolates were first propagated using a modified procedure developed by Onasanya et al. \[[@B18]\]. Nutrient broth (75 mL; pH 7.5) was prepared inside a 100 mL conical flask. Each *Xoo* isolate (100 *μ*L) from storage was transferred into 50 mL of nutrient broth and kept under constant shaking at 30°C for 24 hours for bacterial growth. The bacterial cell was removed by centrifugation, washed with 0.1 mM Tris-EDTA (pH 8.0), and kept at −20°C for DNA extraction.

2.4. Genomic DNA Extraction {#sec2.4}
---------------------------

DNA extraction was according to Onasanya et al. \[[@B20]\] and Onasanya et al. \[[@B18]\] with some modification. 0.3 g of washed bacterial cell was suspended in 200 *μ*L of cetyltrimethylammonium bromide (CTAB) buffer (50 mM Tris, pH 8.0; 0.7 mM NaCl; 10 mM EDTA; 2% hexadecyltrimethylammonium bromide; 0.1% 2-mercaptoethanol), followed by 100 *μ*L of 20% sodium dodecyl sulfate, and incubated at 65°C for 20 min. DNA was purified by two extractions with chloroform and precipitated with −20°C absolute ethanol. After being washed with 70% ethanol, the DNA was dried and resuspended in 200 *μ*L of sterile distilled water. DNA concentration was measured using DU-65UV spectrophotometer (Beckman Instruments Inc., Fullerto, CA, USA) at 260 nm. DNA quality was checked on a 1% agarose gel in Tris-acetate-EDTA (TAE) buffer (45 mM Tris-acetate, 1 mM EDTA, pH 8.0) after electrophoreses.

2.5. RAPD-PCR Analysis {#sec2.5}
----------------------

This analysis was performed according to Onasanya et al. \[[@B20]\]. DNA primers used were purchased from Operon Technologies (Alameda, CA, USA) and each was ten nucleotides long. Two concentrations of each DNA (25 and 95 ng per reaction) were used to test reproducibility and eliminate sporadic amplification products from the analysis. Sixty primers (OPP, OPQ, OPR, OPS, OPT, OPV, OPX, and OPY series) were screened with DNA of two *Xoo* isolates (Virulence,*Vr,* and mildly virulence, *MVr,*isolates) for their ability to amplify the *Xoo* genomic DNA. Primers that gave useful polymorphisms were selected and used in amplifying the DNA from all *Xoo*isolates. Amplification was performed in 25 *μ*L reaction mixture consisting of genomic DNA; reaction buffer (Promega); 100 *μ*M each of dATP, dCTP, dGTP, and dTTP; 0.2 *μ*M Operon random primer; 2.5 *μ*M MgCl~2~, and 1U of Taq polymerase (Boehringer, Germany). A single primer was used in each reaction. Amplification was performed in a Thermowell microtiter plate (Costa Corporation) using an MJ Research Programmable Thermal Controller. The cycling program was (i) 1 cycle of 94°C for 3 min; (ii) 45 cycles of 94°C for 1 min for denaturation, 40°C for 1 min for annealing of primer, and 72°C for 2 min for extension; and (iii) a final extension at 72°C for 7 min. Amplification products were maintained at 4°C until electrophoresis.

2.6. Electrophoresis of PCR Products {#sec2.6}
------------------------------------

The amplification products were resolved by electrophoresis in a 1.4% agarose gel using Tris-acetate-EDTA (TAE) buffer (45 mM Tris-acetate, 1 mM EDTA, pH 8.0) at 100 V for 2 h. A 1 kb ladder (Life Technologies, Gaithersburg, MD, USA) was included as molecular size marker. Gels were visualized by staining with ethidium bromide solution (0.5 *μ*g/mL) and banding patterns were photographed over UV light using UVP-computerized gel photo documentation system.

2.7. Cluster Analysis {#sec2.7}
---------------------

Positions of scorable amplified DNA bands were transformed into a binary character matrix ("1" for the presence and "0" for the absence of a band at a particular position). Pairwise distance matrices were compiled by the Numerical Taxonomy System (NTSYS) 2.0 software \[[@B21]\] using the Jaccard coefficient of similarity \[[@B22]\]. Cluster dendrogram was created by unweighted pair-group method arithmetic (UPGMA) cluster analysis \[[@B23]\]. Principal component analysis with GGE biplot was carried out on 50 *Xoo* isolates using genetic data generated from twelve Operon primers \[[@B24]\].

3. Results and Discussion {#sec3}
=========================

Genetic analysis of fifty *Xanthomonas oryzae*pv*oryzae* (*Xoo*) isolates from West Africa has been carried out. After screening of 60 Operon primers with genomic DNA of two *Xoo* isolates (virulent pathotype, *Vr*, and mildly virulent pathotype, *MVr*), only 12 primers gave reproducible polymorphism and useful genetic information that differentiated the fifty *Xoo* isolates. Amplification with the 12 primers generated 210 bands from which 136 (64.8%) was polymorphic ([Table 2](#tab2){ref-type="table"}) with sizes ranging between 0.5 and 4.0 kb ([Figure 1](#fig1){ref-type="fig"}). Using the 136 RAPD markers ([Table 2](#tab2){ref-type="table"}) in cluster and principal component analyses revealed two major (*Mta* and *Mtb*) molecular typing virulence genotypes among fifty *Xoo* isolates (Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). *Mta* genotype was made up of 42 virulence (*Vr*) *Xoo* isolates with two subgroup genotypes (*Mta1* and *Mta2*). *Mta1* (*Vr1*) subgroup genotype was typical of 25 *Xoo* isolates with 50% occurrence in six countries (Niger, Benin Republic, Nigeria, Burkina Faso, Mali, and Guinea) ([Table 3](#tab3){ref-type="table"}). *Mta2* (*Vr2*) subgroup genotype was typical of 17 *Xoo* isolates with 34% occurrence in three countries (Mali, Guinea, and The Gambia) ([Table 3](#tab3){ref-type="table"}). *Mtb* genotype characterized 8 mildly virulence (*MVr*) *Xoo* isolates with 16% occurrence in five countries (Niger, Benin Republic, Nigeria, Burkina Faso, and Guinea) ([Table 3](#tab3){ref-type="table"}). Thus in Niger, Benin Republic, Nigeria, and Burkina Faso molecular typing revealed the presence of *Mta1* (*Vr1*) and *Mtb* (*MVr*) *Xoo* genotypes; *Mta1*(*Vr1*), and *Mta2*(*Vr2*) genotypes in Mali; *Mta1*(*Vr1*), *Mta2*(*Vr2*), and *Mtb*(*MVr*) genotypes in Guinea; and *Mta2* (*Vr2*) genotype in The Gambia ([Figure 4](#fig4){ref-type="fig"}, [Table 3](#tab3){ref-type="table"}).

Molecular basis for African *Xoo* virulence identification is a prerequisite to understanding the genetics of *Xoo* virulence population structure in West Africa and deployment of durable resistance cultivars \[[@B1], [@B2], [@B25]\]. The present study examined if the two *Xoo* virulence pathotypes (*Pta* and *Ptb*) obtained using phenotypic pathotyping by Onasanya et al. \[[@B4]\] could be confirmed using molecular approach. Molecular typing using random amplified polymorphic (RAPD) markers has revealed two major (*Mta* and *Mtb*) virulence genotypes among the 50 *Xoo* isolates in which *Mta* was virulence (*Vr*) and *Mtb* mildly virulence (*MVr*). This paper supports recent isozyme fingerprints of 30 *Xoo* isolates from 5 countries (Mali, Burkina Faso, Niger, Benin Republic, and Nigeria) in West Africa and molecular analysis of 25 *Xoo* isolates from East Africa that revealed two major genetic groups \[[@B10], [@B11], [@B30]\]. These two genotypes of *Xoo* virulence identified by molecular typing were very identical to*Xoo* virulence pathotypes (*Pta* and *Ptb*) obtained using phenotypic pathotyping indicating possible linkage and correlation between phenotypic pathotyping and molecular typing of *Xoo* virulence \[[@B25], [@B26]\]. Besides, in other studies more variation has been observed within *Xoo* populations rather than between populations which might possibly explain the *Mta1* and *Mta2* subgroups obtained in the present study \[[@B31]\]. Moreover, incongruent relationship between different methods has been previously observed whereas the present study observed similar dendrogram relationships with different methods \[[@B31]\].

The high distinction pattern of each isolates in this study suggests possible high level of genetic variation and frequent occurrence of mutants in *Xoo* isolates in different host cells \[[@B10], [@B28], [@B27]\]. The genetic analyses revealed that *Mta* virulence genotype might cover about 84% of BLB population across Niger, Benin Republic, Nigeria, Burkina Faso, Mali, the Gambia, and Guinea and possibly be responsible for most sporadic cultivars infestation and epidemics in these countries. Also, the existence of *Mta1* and *Mta2* subgroups was likely due to mutations and interactions among isolates and strains that originally constituted *Mta* genotype \[[@B11], [@B18], [@B28], [@B29]\]. Mtb genotype existed in over 16% of BLB population across Niger, Benin Republic, Nigeria, Burkina Faso, and Guinea and might be responsible for most sporadic cultivars infestation and epidemics in these countries. *Mta1* (*Vr1*) and *Mtb* (*MVr*) genotypes were found to exist in Niger, Benin Republic, Nigeria, and Burkina Faso; *Mta1*and *Mta2* in Mali; *Mta1*, *Mta2*,and *Mtb* in Guinea; and *Mta2*in The Gambia, suggesting possible*Xoo* pathogen migration between these countries and long-term *Xoo* pathogen survival \[[@B1], [@B4], [@B18]\].

Distinct phenotypes usually consist of isolates that are genetically less related and such identification of isolates using cultural and morphological techniques often lacks consistency and precision \[[@B4]\]. Molecular typing of *Xoo* virulence has proven particularly useful in situations where it is necessary to differentiate virulence among two or more bacterial pathogens \[[@B18], [@B20], [@B26]\]. In the current study, it was discovered that identification of virulence in *Xoo* depends on different host origins and occurrence of mutants. For instance, *Mta* virulence genotype might cover about 84% of BLB population across Niger, Benin Republic, Nigeria, Burkina Faso, Mali, The Gambia, and Guinea, and *Mtb* genotype existed in over 16% of BLB population across Niger, Benin Republic, Nigeria, Burkina Faso, and Guinea, but isolates virulence distributions vary within subgroups. Based on phylogenetic study, it was discovered that after prolonged season-to-season interactions among isolates of *Mta* or *Mtb* genotype in different cultivated rice and weed hosts, different subgroup virulence genotypes (*Mta1* and *Mta2*) may emerge as a result of mutation \[[@B18], [@B20], [@B27]\]. The emerged subgroup virulence genotypes might result in occurrence of highly virulent isolates and strains with very broad interaction and pathogenicity across wide range of cultivated rice varieties across West African countries.

4. Conclusions {#sec4}
==============

The present molecular study of *Xoo* virulence identified two major *Xoo* virulence genotypes (*Mta* and *Mtb*) and two subgroups (*Mta1* and *Mta2*). Existence of different Xoo virulence genotypes suggests high level of *Xoo* pathogen interaction with host cells and mutation. The study revealed possible linkage between *Xoo* virulence pathotype and *Xoo* virulence genotype. Difference *Xoo* virulence genotypes were known to exist within country and there was evidence of *Xoo* pathogen migration between countries. Durable resistance rice cultivars would need to overcome both *Mta* and *Mtb Xoo* virulence genotypes in order to survive after their deployment into different rice ecologies in West Africa.

The authors are very grateful to the Central Biotechnology Laboratory, International Institute of Tropical Agriculture (IITA), Nigeria, for funding this research.

![DNA fingerprinting patterns of 50 *Xanthomonas oryzae*pv.*oryzae*(*Xoo*) isolates using OPS-08 random amplified polymorphic DNA primer. M: 1kb molecular size marker; kb: kilobase pair. *Xoo* isolates: 1 = XN-1; 2 = XN-2; 3 = XN-3; 4 = XN-4; 5 = XN-5; 6 = XN-6; 7 = XB-7; 8 = XB-8; 9 = XB-9; 10 = XB-10; 11 = XB-11; 12 = XNG-12; 13 = XNG-13; 14 = XNG-14; 15 = XNG-15; 16 = XNG-16; 17 = XBF-17; 18 = XBF-18; 19 = XBF-19; 20 = XBF-20; 21 =X BF-21; 22 = XBF-22; 23 = XM-23; 24 = XM-24; 25 = XM-25; 26 = XM-26; 27 = XM-27; 28 = XM-28; 29 = XM-29; 30 = XM-30; 31 = XG-31; 32 = XG-32; 33 = XG-33; 34 = XG-34; 35 = XG-35; 36 = XG-36; 37 = XG-37; 38 = XG-38; 39 = XG-39; 40 = XG-40; 41 = XTG-41; 42 = XTG-42; 43 = XTG-43; 44 = XTG-44; 45 = XTG-45; 46 = XTG-46; 47 = XTG-47; 48 = XTG-48; 49 = XTG-49; 50 = XTG-50.](ISRN.MOLECULAR.BIOLOGY2013-160157.001){#fig1}

![Molecular typing of 50 *Xanthomonas oryzae*pv.*oryzae* (*Xoo*) virulence as revealed by 136 random amplified polymorphic DNA markers. *Mta*: molecular type a; *Mtb*: molecular type b; *Vr*: virulence; *MVr*: mildly virulence. *Xoo* isolates: 1 = XN-1; 2 = XN-2; 3 = XN-3; 4 = XN-4; 5 = XN-5; 6 = XN-6; 7 = XB-7; 8 = XB-8; 9 = XB-9; 10 = XB-10; 11 = XB-11; 12 = XNG-12; 13 = XNG-13; 14 = XNG-14; 15 = XNG-15; 16 = XNG-16; 17 = XBF-17; 18 = XBF-18; 19 = XBF-19; 20 = XBF-20; 21 = XBF-21; 22 = XBF-22; 23 = XM-23; 24 = XM-24; 25 = XM-25; 26 = XM-26; 27 = XM-27; 28 = XM-28; 29 = XM-29; 30 = XM-30; 31 = XG-31; 32 = XG-32; 33 = XG-33; 34 = XG-34; 35 = XG-35; 36 = XG-36; 37 = XG-37; 38 = XG-38; 39 = XG-39; 40 = XG-40; 41 = XTG-41; 42 = XTG-42; 43 = XTG-43; 44 = XTG-44; 45 = XTG-45; 46 = XTG-46; 47 = XTG-47; 48 = XTG-48; 49 = XTG-49; 50 = XTG-50.](ISRN.MOLECULAR.BIOLOGY2013-160157.002){#fig2}

![Principal component analysis that revealed subgroup virulence genotypes among 50 *Xanthomonas oryzae*pv.*oryzae* isolates using genetic data generated from twelve random amplified polymorphic DNA (RAPD) primers.](ISRN.MOLECULAR.BIOLOGY2013-160157.003){#fig3}

![*Xanthomonas oryzae* pv. *oryzae* isolates virulence genotype population structure status in West Africa. *Mta*: molecular type a; *Mtb*: molecular type b; *Vr*: virulence; *MVr*: mildly virulence. Country: C1: Niger; C2: Benin Republic; C3: Nigeria; C4: Burkina Faso; C5: Mali; C6: Guinea; C7: The Gambia.](ISRN.MOLECULAR.BIOLOGY2013-160157.004){#fig4}

###### 

Identity of *Xanthomonas oryzae*pv.*oryzae* isolates used for the study.

  S/N   Isolates codes∗   Host plant   Country
  ----- ----------------- ------------ --------------
  1     XN-1              D52-37       Niger
  2     XN-2              D52-37       Niger
  3     XN-3              IR15296829   Niger
  4     XN-4              IR15296829   Niger
  5     XN-5              WITA 8       Niger
  6     XN-6              WITA 8       Niger
  7     XB-7              Local        Benin
  8     XB-8              Local        Benin
  9     XB-9              Local        Benin
  10    XB-10             Local        Benin
  11    XB-11             Local        Benin
  12    XNG-12            WITA9        Nigeria
  13    XNG-13            WITA9        Nigeria
  14    XNG-14            WITA 4       Nigeria
  15    XNG-15            WITA 4       Nigeria
  16    XNG-16            WITA 8       Nigeria
  17    XBF-17            TS2          Burkina Faso
  18    XBF-18            TS2          Burkina Faso
  19    XBF-19            FKR14        Burkina Faso
  20    XBF-20            FKR19        Burkina Faso
  21    XBF-21            FKR14        Burkina Faso
  22    XBF-22            Chinese      Burkina Faso
  23    XM-23             Adventices   Mali
  24    XM-24             Kogoni       Mali
  25    XM-25             Kogoni       Mali
  26    XM-26             Kogoni       Mali
  27    XM-27             Kogoni       Mali
  28    XM-28             Kogoni       Mali
  29    XM-29             Jamajigi     Mali
  30    XM-30             Nionoka      Mali
  31    XG-31             Weed         Guinea
  32    XG-32             Weed         Guinea
  33    XG-33             Weed         Guinea
  34    XG-34             Local        Guinea
  35    XG-35             Local        Guinea
  36    XG-36             Local        Guinea
  37    XG-37             Local        Guinea
  38    XG-38             Local        Guinea
  39    XG-39             Local        Guinea
  40    XG-40             Local        Guinea
  41    XTG-41            Local        The Gambia
  42    XTG-42            Local        The Gambia
  43    XTG-43            Local        The Gambia
  44    XTG-44            Local        The Gambia
  45    XTG-45            Local        The Gambia
  46    XTG-46            Local        The Gambia
  47    XTG-47            Local        The Gambia
  48    XTG-48            Local        The Gambia
  49    XTG-49            Weed         The Gambia
  50    XTG-50            Weed         The Gambia

^\*^ *Xanthomonas oryzae*pv.*oryzae* isolates obtained from \[[@B4]\].

###### 

Oligonucleotide primers that showed genetic discrimination among the *Xanthomonas oryzae*pv.*oryzae* isolates using random amplified polymorphic DNA polymerase chain reaction analysis.

  Operon primer   Nucleotide sequence 5′ to 3′   No. of fragments amplified   No. of polymorphic bands   \% polymorphism
  --------------- ------------------------------ ---------------------------- -------------------------- -----------------
  OPP-17          TGACCCGCCT                     18                           16                         88.9
  OPP-18          GGCTTGGCCT                     14                           11                         78.6
  OPR-07          ACTGGCCTGA                     20                           11                         55.0
  OPS-08          TTCAGGGTGG                     23                           13                         56.5
  OPS-10          ACCGTTCCAG                     20                           13                         65.0
  OPS-13          GTCGTTCCTG                     16                           9                          56.3
  OPT-09          CACCCCTGAG                     16                           10                         62.5
  OPT-12          GGGTGTGTAG                     13                           7                          53.8
  OPT-15          GGATGCCACT                     18                           10                         55.6
  OPV-05          TCCGAGAGGG                     19                           12                         63.2
  OPY-06          AAGGCTCACC                     16                           11                         68.8
  OPY-08          AGGCAGAGCA                     17                           13                         76.5
                                                                                                         
  Total           210                            136                          64.8                       

###### 

*Xanthomonas oryzae*pv.*oryzae* isolate group, virulence, and distribution relative to country of origin.

  Typing           Main group   Subgroup   Virulence   Isolate origin and distribution   \% Occurrence                                 
  ---------------- ------------ ---------- ----------- --------------------------------- --------------- ----- ----- ----- ----- ----- ----
  Pathotype∗       *Pta*        *Pta*1     *Vr*        ---                               ---             ---   4     1     4     1     20
  *Pta*2           *Vr*         3          ---         ---                               ---             ---   1     4     16          
  *Pta*3           *Vr*         ---        2           3                                 1               2     3     ---   22          
  *Ptb*            *Ptb*1       *MVr*      2           2                                 1               1     1     1     2     20    
  *Ptb*2           *MVr*        1          1           1                                 ---             4     1     3     22          
                                                                                                                                       
  Molecular type   *Mta*        *Mta*1     *Vr*1       4                                 3               3     5     7     3     ---   50
  *Mta*2           *Vr*2        ---        ---         ---                               ---             1     6     10    34          
  *Mtb*            ---          *MVr*      2           2                                 2               1     ---   1     ---   16    

^\*^\[[@B4]\]*; Pta*: pathotype a; *Ptb*: pathotype b; *Mta*: molecular type a; *Mtb*: molecular type b; *Vr*: virulence; *MVr*: mildly virulence.
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